CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

Overview of attention for article published in Journal of Neuroinflammation, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 189 Dimensions

Readers on

mendeley: 157 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHODS OF TREATING AN AUTOIMMUNE DISEASE

Application WO-2020102895-A1

World Intellectual Property Organisation (WIPO)

BIOMARKER SIGNATURES FOR LYME DISEASE DIFFERENTIATION AND METHODS OF USE THEREOF

Application EP-3400441-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.